Fast Five Quiz: Chronic Migraine Prevention

Stephanie J. Nahas, MD, MSEd; Helmi L. Lutsep, MD

Disclosures

February 04, 2022

As with abortive medications, the choice of a preventive medication for patients with chronic migraine must include consideration of comorbid conditions and the side-effect profile. Beta-blockers are among the first-line agents for migraine prophylaxis, and two are approved by the US Food and Drug Administration (FDA) for migraine prevention (propranolol and timolol). However, beta-blockers should not be used as a first-line agent for patients over 60 years who smoke. Other first-line agents include tricyclic antidepressants (not FDA-approved) and two anticonvulsants, divalproex sodium and topiramate (both FDA-approved). The only therapy FDA-approved specifically for prevention of chronic migraine is onabotulinumtoxinA.

Learn more about the management of chronic migraine.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....